UBP Greater China (Shanghai) Co., Ltd   Report issue

For profit Phase 1 Phase 2
Founded: Shanghai China (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2020
NCT04404049
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

UBP Greater China (Shanghai) Co., Ltd

Active Ingredients

Drugs in Phase 2 Trials (3)

chidamide (1 trial)

ub-421 (2 trials)

ub-621 (2 trials)

Drugs in Phase 1 Trials (1)

ub-221 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Urticaria (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 4